Cargando…
Comparative performance of CRISPR-Cas12a assays for SARS-CoV-2 detection tested with RNA extracted from clinical specimens
COVID-19 pandemic caused by SARS-CoV-2 infection continue to cause the morbidity and mortality in many countries. Limitations of the gold standard qRT-PCR for diagnosis of this infection includes need for expensive equipment, specialized molecular laboratory, and experienced staff. Currently, CRISPR...
Autores principales: | Nimsamer, Pattaraporn, Mayuramart, Oraphan, Rattanaburi, Somruthai, Chantaravisoot, Naphat, Saengchoowong, Suthat, Puenpa, Jiratchaya, Poovorawan, Yong, Payungporn, Sunchai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849546/ https://www.ncbi.nlm.nih.gov/pubmed/33539846 http://dx.doi.org/10.1016/j.jviromet.2021.114092 |
Ejemplares similares
-
IRF7-deficient MDCK cell based on CRISPR/Cas9 technology for enhancing influenza virus replication and improving vaccine production
por: Mayuramart, Oraphan, et al.
Publicado: (2022) -
In Silico Evaluation of CRISPR-Based Assays for Effective Detection of SARS-CoV-2
por: Kaewsapsak, Pornchai, et al.
Publicado: (2022) -
Genome characterization and mutation analysis of human influenza A virus in Thailand
por: Rattanaburi, Somruthai, et al.
Publicado: (2022) -
Machine Learning-Driven and Smartphone-Based Fluorescence
Detection for CRISPR Diagnostic of SARS-CoV-2
por: Samacoits, Aubin, et al.
Publicado: (2021) -
Investigation of the Molecular Epidemiology and Evolution of Circulating Severe Acute Respiratory Syndrome Coronavirus 2 in Thailand from 2020 to 2022 via Next-Generation Sequencing
por: Puenpa, Jiratchaya, et al.
Publicado: (2023)